Skip to main content
ConductScienceScienceDex

Douglas M McCarty

NIH Rank #1952
Unclaimed recordClaim profile
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6409365Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$4.1M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#1,952
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Douglas M McCarty. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Douglas M McCarty as a PI. Multi-PI records show the full award amount for context.

  • 1R44NS143501-01R44
    Trans-BBB AAV9 gene therapy targeting CNS neuropathy of MPS I
    Neurogt, Inc.
    $1.5M
    award amount
  • 4R44NS135667-02R44
    Development of gene therapy product for treating MPS IIIB
    Neurogt, Inc.
    $1.3M
    award amount
  • 5R44AI172670-03R44
    Protein depleting pre-existing antibodies for viral gene therapy
    Neurogt, Inc.
    $969.8K
    award amount
  • 1R41NS143578-01R41
    Novel AAV gene therapy for treating CNS neuropathy of MPS IIIC
    Neurogt, Inc.
    $349.9K
    award amount

Award organization

Organizations that administered FY2025 awards listing Douglas M McCarty as a PI.

FY2025 award administered by Neurogt, Inc. (NC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Neurogt, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #9033
  5. 2025
    $2M Cumulative Funding
  6. 2025
    $5M Cumulative Funding
  7. 2025
    Entered Top 25% Nationally
    Ranked #1952
  8. 2025
    Entered Top 10% Nationally
    Ranked #1952

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Douglas M McCarty.

Haiyan Fu
Neurogt, Inc.
2
shared awards

Explore further

Find collaborators for Douglas M McCarty

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →